revealed that acetylation‐mediated degradation of BCAT2 can retard development of pancreatic ductal adenocarcinoma (PDAC) by downregulating metabolism level of BCAAs.[22] Wang et al. This evidence concerns the gene BCAT2 and pancreatic ductal adenocarcinoma.